| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 07/25/2013 | WO2013108837A1 Pyrazole derivative with tlr inhibiting properties |
| 07/25/2013 | WO2013107761A1 Substituted triazoles and their use for treatment and/or prevention neurological and psychiatric disorders |
| 07/25/2013 | WO2013107278A1 New-type anti-cancer compounds synthesized from reaction of ketone and indole derivatives |
| 07/25/2013 | WO2013042124A8 Use of strigolactones and strigolactone analogs for treating proliferative conditions |
| 07/25/2013 | US20130190506 Process for olmesartan medoxomil |
| 07/25/2013 | US20130190488 Apoptosis promoters |
| 07/25/2013 | US20130190350 Mediators of Hedgehog Signaling Pathways, Compositions and Uses Related Thereto |
| 07/25/2013 | US20130190338 Sulfur derivatives as chemokine receptor modulators |
| 07/25/2013 | US20130190309 Phthalazinone and related analogs as sirtuin modulators |
| 07/25/2013 | US20130190302 Modulators of amyloid beta |
| 07/25/2013 | US20130190296 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 07/25/2013 | US20130190273 Methods for Treating Amyotrophic Lateral Sclerosis Using Pro-Neurogenic Compounds |
| 07/25/2013 | US20130188270 Oxime ester |
| 07/25/2013 | CA2863517A1 Substituted pyrimidine compounds and their use as syk inhibitors |
| 07/24/2013 | EP2617720A1 Novel cortistatin a analog and use thereof |
| 07/24/2013 | EP2617712A1 Nitrogen-containing aromatic heterocyclic derivative and organic electroluminescence device using same |
| 07/24/2013 | EP2617419A1 Aza spiro alkane derivatives as inhibitors of metallproteases |
| 07/24/2013 | EP2616462A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 07/24/2013 | EP2616461A2 Potent and selective inhibitors of hepatitis c virus |
| 07/24/2013 | EP2616460A1 Heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine. |
| 07/24/2013 | EP2616459A1 Pyridine compounds for controlling invertebrate pests i |
| 07/24/2013 | EP2616450A2 Sulfonamide compounds |
| 07/24/2013 | EP2616443A1 Phtalazine derivatives as jak1 inhibitors |
| 07/24/2013 | EP2616442A1 Inhibitors of pi3k-delta and methods of their use and manufacture |
| 07/24/2013 | EP2615916A1 Fused pyrazole derivatives as novel erk inhibitors |
| 07/24/2013 | CN1989122B Novel cylopenta[b]benzofuran derivatives and the utilization thereof |
| 07/24/2013 | CN1980899B Quinazolinone derivatives as parp inhibitors |
| 07/24/2013 | CN103221407A Oxygenated fused ring derivative and organic electroluminescence element containing the same |
| 07/24/2013 | CN103221406A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 07/24/2013 | CN103221402A Triazole derivatives and their use for neurological disorders |
| 07/24/2013 | CN103221397A New compositions and methods for controlling nematode pests |
| 07/24/2013 | CN103221395A Insecticidal compounds |
| 07/24/2013 | CN103214470A Novel anticancer compound synthesized by reaction of ketone and indole derivative |
| 07/24/2013 | CN103214469A Olmesartan medoxomil compound and preparation method thereof |
| 07/24/2013 | CN103214460A Chemical compounds |
| 07/24/2013 | CN103214457A Azole antifungal compound, its preparation method and application |
| 07/24/2013 | CN103214451A Bicyclol amino-acid ester as well as preparation method and application for same |
| 07/24/2013 | CN103214450A Modulators of atp-binding cassette transporters |
| 07/24/2013 | CN103214416A Method for synthesizing multi-substituted quinoline compound |
| 07/24/2013 | CN102219751B Pentadienone-containing 4-substituted quinazoline derivative, preparation method and use thereof |
| 07/24/2013 | CN102112439B 5-heterocyclylalkyl-3-hydroxy-2-phenylcyclopent-2-enones as herbicides |
| 07/24/2013 | CN102093341B Indole ring substituted pyrazole carboxylic acid endothelin receptor antagonist as well as preparation method and application thereof |
| 07/23/2013 | US8492560 Quinazoline derivatives as angiogenesis inhibitors |
| 07/23/2013 | US8492549 2,3-dihydrobenzo(1,4) dioxin-2-ylmethyl derivatives as alpha2C antagonists for use in the treatment of peripheric and central nervous systeme diseases |
| 07/23/2013 | US8492416 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 07/23/2013 | US8492375 1-benzoyl substituted diazepine derivatives as selective histamine H3 receptor agonists |
| 07/23/2013 | US8492372 Modulators of dopamine neurotransmission |
| 07/23/2013 | US8492111 Arylalkylamine compound and process for preparing the same |
| 07/23/2013 | CA2607106C 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility |
| 07/23/2013 | CA2599348C Indole compound and use thereof |
| 07/18/2013 | WO2013106819A2 Zinc-responsive peptides, and methods of use thereof |
| 07/18/2013 | WO2013106409A1 Benzamide derivatives as modulators of the follicle stimulating hormone |
| 07/18/2013 | WO2013105676A1 Benzimidazole derivatives as mch receptor antagonists |
| 07/18/2013 | WO2013105608A1 P2x4 receptor antagonist |
| 07/18/2013 | WO2013104705A1 Tetrazol-5-yl- and triazol-5-yl-aryl compounds and use thereof as herbicides |
| 07/18/2013 | WO2013104573A1 Pyridazine amide compounds and their use as syk inhibitors |
| 07/18/2013 | WO2013104257A1 Polycyclic derivatives, preparation method and medical uses thereof |
| 07/18/2013 | WO2012068366A9 Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus |
| 07/18/2013 | US20130184465 Process for the synthesis of thio-triazolo-group containing compounds |
| 07/18/2013 | US20130184460 Glycine transporter inhibiting substances |
| 07/18/2013 | US20130184299 Ccr2 antagonists and uses thereof |
| 07/18/2013 | US20130184298 Dihydrobenzoquinazolinone m1 receptor positive allosteric modulators |
| 07/18/2013 | US20130184297 Quinazoline derivatives substituted by aniline, preparation method and use thereof |
| 07/18/2013 | US20130184277 Adamantyl diamide derivatives and uses of same |
| 07/18/2013 | US20130184259 Pyridones useful as inhibitors of kinases |
| 07/18/2013 | US20130184258 Compositions Useful as Inhibitors of Voltage-Gated Sodium Channels |
| 07/18/2013 | US20130184251 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors |
| 07/18/2013 | US20130184248 Novel compounds |
| 07/18/2013 | US20130184241 Naphthalene Derivative |
| 07/18/2013 | CA2860808A1 Benzamide derivatives as modulators of the follicle stimulating hormone |
| 07/17/2013 | EP2615086A1 2,4-Diaminoquinazolines for the treatment of spinal muscular atrophy |
| 07/17/2013 | EP2615085A1 Pyridyl derivatives as CFTR modulators |
| 07/17/2013 | EP2614055A2 Process for preparation of substantially pure fosamprenavir calcium and its intermediates |
| 07/17/2013 | CN103209963A 2-quinolinyl-acetic acid derivatives as HIV antiviral compounds |
| 07/17/2013 | CN103209962A Substituted 6-amino-nicotinamides as kcnq2/3 modulators |
| 07/17/2013 | CN103209960A Sulfonamide compounds useful as CYP17 inhibitors |
| 07/17/2013 | CN103204817A Preparation method for 4-cyanoquinoline derivatives |
| 07/17/2013 | CN102153606B Nucleoside derivatives as well as stereo isomers, pharmaceutically acceptable salts and application thereof |
| 07/17/2013 | CN101998951B Acylthiourea compound or salt thereof, and use thereof |
| 07/17/2013 | CN101663270B Quaternary ammonium compounds useful as muscarinic receptor antagonists |
| 07/17/2013 | CN101641339B Compounds for the prevention and treatment of cardiovascular diseases |
| 07/17/2013 | CN101479008B Benzoazepin-oxy-acetic acid derivatives as PPAR-delta agonists used for the increase of HDL-C, lower HDL-C and lower cholesterol |
| 07/17/2013 | CN101415683B New compounds |
| 07/17/2013 | CN101374815B Cyanoisoquinoline compounds that stabilize hypoxia inducible factor (HIF) |
| 07/17/2013 | CN101203495B Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase MET |
| 07/16/2013 | US8487112 Method for producing 4-aminobut-2-enolides |
| 07/16/2013 | US8486979 Analgesics; central nervous system disorders; attentiondeficit disorders;cognition activators; bipolar disorders; Alzheimer's disease; Down's syndrome; brain disorders |
| 07/16/2013 | US8486974 Efficient aspirin prodrugs |
| 07/16/2013 | US8486400 Methods of inhibiting unwanted cell proliferation using an antibody that binds to sonic hedgehog and inhibits hedgehog signaling |
| 07/16/2013 | CA2697167C Benzimidazole derivatives used as fxr agonists |
| 07/16/2013 | CA2583983C Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 07/16/2013 | CA2569826C Substituted 2-alkyl quinazolinone derivatives as parp inhibitors |
| 07/11/2013 | WO2013102992A1 Material for organic electroluminescence element and element using same |
| 07/11/2013 | WO2013049352A3 Anti-viral compounds |
| 07/11/2013 | US20130178502 Pyridine Compounds for Controlling Invertebrate Pests I |
| 07/11/2013 | US20130178480 Inhibitors of Advanced Glycation End Products |
| 07/11/2013 | US20130178471 Modulators of atp-binding cassette transporters |
| 07/11/2013 | US20130178461 Inhibitors of bruton's tyrosine kinase |
| 07/11/2013 | US20130178458 Substituted (1-(methylsulfonyl)azetidin-3-yl)(heterocycloalkyl)methanone analogs as antagonists of muscarinic acetylcholine m1 receptors |
| 07/11/2013 | US20130178457 Cannabinoid receptor modulators |